Accession ID: MIRT003274 [miRNA, hsa-miR-30d ::
GNAI2, target gene]
| pre-miRNA ID | hsa-mir-30d LinkOut: [miRBase ] |
|---|---|
| Description | Homo sapiens miR-30d stem-loop |
| 2nd Structure of pre-miRNA | ![]() |
| Mature miRNA | hsa-miR-30d-3p |
|---|---|
| Mature Sequence | 46| CUUUCAGUCAGAUGUUUGCUGC |67 |
| Evidence | Experimental |
| Experiments | Cloned |
| Putative hsa-miR-30d-3p Targets | LinkOut: [ TargetScanS 5.1 | MicroCosm | microRNA.org | miRecords | miRDB | miRo | miRNAMap 2.0 ] |
| Mature miRNA | hsa-miR-30d-5p |
| Mature Sequence | 6| UGUAAACAUCCCCGACUGGAAG |27 |
| Evidence | Experimental |
| Experiments | Cloned |
| Putative hsa-miR-30d-5p Targets | LinkOut: [ TargetScanS 5.1 | MicroCosm | microRNA.org | miRecords | miRDB | miRo | miRNAMap 2.0 ] |
![]() |
| Gene Symbol | GNAI2 LinkOut: [ Entrez Gene | BioGPS | Wikipedia | iHop ] | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms | GIP, GNAI2B, H_LUCA15.1, H_LUCA16.1 | ||||||||||||||||||||
| Description | guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 | ||||||||||||||||||||
| Transcript | NM_001166425 LinkOut: [ RefSeq ] | ||||||||||||||||||||
| Other Transcripts | NM_002070 | ||||||||||||||||||||
| Expression | LinkOut: [ BioGPS ] | ||||||||||||||||||||
| KEGG Pathway |
hsa04062 Chemokine signaling pathway - Homo sapiens (human) hsa04360 Axon guidance - Homo sapiens (human) hsa04530 Tight junction - Homo sapiens (human) hsa04540 Gap junction - Homo sapiens (human) hsa04670 Leukocyte transendothelial migration - Homo sapiens (human) hsa04730 Long-term depression - Homo sapiens (human) hsa04914 Progesterone-mediated oocyte maturation - Homo sapiens (human) hsa04916 Melanogenesis - Homo sapiens (human) hsa05142 Chagas disease - Homo sapiens (human) |
||||||||||||||||||||
| Putative miRNA Targets on GNAI2 | LinkOut: [ TargetScan 5.1 | MicroCosm | miRNAMap 2.0 ] | ||||||||||||||||||||
| 3'UTR of GNAI2 (miRNA target sites are highlighted) |
>GNAI2|NM_001166425|3'UTR 1 TGAGGGGCAGCGGGGCCTGGCGGGATGGGCCACCGCCGACTTTGTACCCCCCAACCCCTGAGGAAGATGGGGGCAAGAAG 81 ATCACGCTCCCCGCCTGTTCCCCCGCCGCTTTTCTCCTCTTTCCTCTCTTTGTTCTCAGCTCCCCCTGTCCCCTCAGCTC 161 CAGACGTAGGGGAGGGGTTGCCACAGGCCTCCCTGTTTGAAGCCTGCCCTTGTCTGAGATGCTGGTAATGGCCATGGTAC 241 CCCCTTCTGGGCATCTGTTCTGGTTTTTAACCATTGTCTTGTTCTGTGATGAGGGGAGGGGGGCACATGCTGAGTCTCCC 321 AAGGCTGCGTCTGGAGGGGCCCCTGCTTCTCCAGCCTGGACCCCCAGCTTTGCCCAACACCAGCCCCTGCCCCAGCCCAA 401 GTCCAAATGTTTACAGGGAGCCTCCTGCCCAGTCCCCCAACCCCAGCCGCTCGGAGGCCCCAAAGGAAAAAGCACAAGAA 481 GCGTGAGACGCCACCATTCCTGGAAACCACAGTCCACCTGCTCATTCTCGTAGCTTTTTAAAAAAATGAAAGTAAAGGAA 561 AAAAAAAAAACTGCAAATCTAGAAAACTTTTTAGAGAAAAACTATTTAAAACTGTCAGATCCTGACCAGCAAGCCCCCCC 641 CCAGCCCCCCTTCCAAGTGACTCCGTGCCTTGAGTGTGTCTGCGTGTTTACACCCGTCCCTCTGCTGGCCGCCCCCGTGC 721 GAGCGGCACCCCTGCCCTGCCCTCCACAGAATTGGGTTCCAAGGGCTGTTCCAGACAACTGCCAACGTCACTGAGGGCCC 801 TGCCCCAGCGGCCCTGGCCCCAGGCTCTATTAACCTAAAATGTAGCTCCCTAGCGCTAACCTAGGAACCGCCGCTGCCTG 881 CTGGGGGGCCACGCCCCTCATGCCCTTGTCCCAGGCCCGGGGCCTTCAGCGTTGAACACTTCCTTGCTTTTTTCACATGT 961 TTTATGGAATTGTTCACCTGGTTTGAAATAATAAAATGTAGAAAGAAAAAAAAT Target sites Provided by authors Predicted by miRanda |
||||||||||||||||||||
| miRNA-target interactions (Predicted by miRanda) |
|
| miRNA:Target | hsa-miR-30d :: GNAI2 [ Functional MTI ] | ||||||
|---|---|---|---|---|---|---|---|
| Validation Method | Western blot | ||||||
| Conditions | HEK293T | ||||||
| Location of target site | 3'UTR | ||||||
| Tools used in this research | microRNA.org, miRanda, PicTar, TargetScan | ||||||
| Original Description (Extracted from the article) | ... miR-30d Posttranscriptionally Down-regulates GNAI2 Expression by Directly Targeting Its 3`-UTR. ... - Yao, J. Liang, L. Huang, S. Ding, J. Tan, et al., 2010, Hepatology. |
||||||
| miRNA-target interactions (Provided by authors) |
|
||||||
| Article |
- Yao, J.
Liang, L.
Huang, S.
Ding, J.
Tan, et al. - Hepatology, 2010
The pathological relevance and significance of microRNAs (miRNAs) in hepatocarcinogenesis have attracted much attention in recent years; however, little is known about the underlying molecular mechanisms through which miRNAs are involved in the development and progression of hepatocellular carcinoma (HCC). In this study, we demonstrate that miR-30d is frequently up-regulated in HCC and that its expression is highly associated with the intrahepatic metastasis of HCC. Furthermore, the enhanced expression of miR-30d could promote HCC cell migration and invasion in vitro and intrahepatic and distal pulmonary metastasis in vivo, while silencing its expression resulted in a reduced migration and invasion. Galphai2 (GNAI2) was identified as the direct and functional target of miR-30d with integrated bioinformatics analysis and messenger RNA array assay. This regulation was further confirmed by luciferase reporter assays. In addition, our results, for the first time, showed that GNAI2 was frequently suppressed in HCC by way of quantitative reverse-transcription polymerase chain reaction and immunohistochemical staining assays. The increase of the GNAI2 expression significantly inhibits, whereas knockdown of the GNAI2 expression remarkably enhances HCC cell migration and invasion, indicating that GNAI2 functions as a metastasis suppressor in HCC. The restoration of GNAI2 can inhibit miR-30d-induced HCC cell invasion and metastasis. Conclusion: The newly identified miR-30d/GNAI2 axis elucidates the molecular mechanism of HCC cell invasion and metastasis and represents a new potential therapeutic target for HCC treatment. (HEPATOLOGY 2010.).
LinkOut: [PMID: 20054866]
|

